# Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19

> **NCT04854876** · NA · WITHDRAWN · sponsor: **Royal College of Surgeons in Ireland - Medical University of Bahrain**

## Conditions studied

- SARS-COV 2
- Covid19

## Interventions

- **DIETARY_SUPPLEMENT:** 5-ALA-Phosphate + SFC (5-ALA+SFC)

## Key facts

- **NCT ID:** NCT04854876
- **Lead sponsor:** Royal College of Surgeons in Ireland - Medical University of Bahrain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-08-15
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The food supplement/health product registration needs to be undertaken with NHRA- Pharmaceutical Product Regulations Department
- **Last updated:** 2021-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04854876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04854876, "Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04854876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*